SCHEMBL5838169

SCHEMBL5838169

O=C(O)C1CCCCC1c1ccc(CN2C(=O)c3ccccc3C2=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.52
▸ HDAC1 Q13547 1/20 0.47
▸ HDAC7 Q8WUI4 1/20 0.47
▸ CASP3 P42574 1/20 0.47
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ MT-CO2 P00403 1/20 0.45
▸ ALOX5 P09917 1/20 0.45
▸ KEAP1 Q14145 6/20 0.44
▸ NFE2L2 Q16236 4/20 0.44
▸ ATM Q13315 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ ADRA1D P25100 1/20 0.44
▸ ADRA1A P35348 1/20 0.44
▸ ADRA1B P35368 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA9 Q16790 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6282881 0.77 CASP3 (0.51) ALDH1A1HDAC1HDAC7CASP3KMT2A
SCHEMBL22492062 0.76 KCNQ3 (0.56) ALDH1A1KMT2AMEN1L3MBTL1HPGD
SCHEMBL12354198 0.76 KCNQ3 (0.56) ALDH1A1KMT2AMEN1L3MBTL1HPGD
SCHEMBL838634 0.76 KCNQ3 (0.56) ALDH1A1KMT2AMEN1L3MBTL1HPGD
SCHEMBL22492058 0.76 KCNQ3 (0.56) ALDH1A1KMT2AMEN1L3MBTL1HPGD
SCHEMBL12592461 0.74 SLC6A2 (0.56) KMT2AMEN1HPGD
SCHEMBL1752183 0.74 SLC6A2 (0.56) KMT2AMEN1HPGD
SCHEMBL1752024 0.74 SLC6A2 (0.56) KMT2AMEN1HPGD
SCHEMBL3781297 0.74 KEAP1 (0.56) KEAP1NFE2L2ATML3MBTL1CA12
SCHEMBL9118854 0.74 TBXA2R (0.43) ALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7074780-B2 Substituted phenylcyclohexanecarboxamides and their use BAYER AKTIENGESELLSCHAFT (DE) 2006-07-11 — — US disclosed
US-20040122004-A1 Substituted phenylcyclohexanecarboxamides and their use BAYER AKTIENGESELLSCHAFT (DE) 2004-06-24 — — US disclosed
US-6649616-B2 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia BAYER AKTIENGESELLSCHAFT (DE) 2003-11-18 — — US disclosed
US-20030008881-A1 Substituted phenylcyclohexanecarboxamides and their use BAYER AKTIENGESELLSCHAFT (DE) 2003-01-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030008881-A1 Substituted phenylcyclohexanecarboxamides and their use TNNI3, PAH, P4HA1 ALDH1A1 349/4885HDAC1 339/4885HDAC7 1051/4885
US-20040122004-A1 Substituted phenylcyclohexanecarboxamides and their use TNNI3, PAH, P4HA1 ALDH1A1 349/4885HDAC1 339/4885HDAC7 1051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback